Global Extrapulmonary Tuberculosis: Overview and Epidemiological Profile
Extrapulmonary TB affects parts of the body outside the lungs, such as lymph nodes, bones, the brain and the abdomen, and is harder to diagnose. This report covers TB lymphadenitis, TB meningitis, spinal and bone TB and abdominal TB.
Burden: Prevalence, Incidence and Mortality
The report sets out the prevalence, incidence and, where relevant, deaths from extrapulmonary tuberculosis worldwide, and the overall burden, using TB Incidence, TB Case Notifications, Treatment Success Rate, TB Deaths and Drug-Resistant TB Cases.
Demographic Distribution: Age, Gender and Vulnerable Population Groups
The burden is broken down by age (children 0–14 years, adolescents and young adults 15–24 years, adults 25–54 years and adults 55 years and over), gender and income, with a focus on people living with HIV, people with diabetes, undernourished people, household contacts, miners and prisoners and migrants and the urban poor.
Geographical Distribution: State, District, Urban and Rural Segmentation
Findings are compared across states, provinces and districts where data allows, and between urban, rural and informal settlement areas, to show where needs are greatest and where gaps between places are widest.
Risk Factors and Social Determinants of Health
Main risk factors include HIV infection, undernutrition, diabetes, smoking and alcohol use, crowded and poorly ventilated housing and silica dust exposure. Income, education, housing, water and sanitation, and gender and social norms are reviewed as social drivers of health.
Awareness and Screening Coverage
The report reviews how aware people are of extrapulmonary tuberculosis and how far screening reaches them, through symptom screening, chest x-ray screening, rapid molecular tests and contact investigation, by group and by area.
Diagnosis Rates and Undiagnosed Burden
It compares the number of people diagnosed with the estimated number affected, to show the undiagnosed burden and how many people are lost between screening and treatment.
Treatment, Prevention and Coverage
Treatment and prevention covered include biopsy and fluid testing, molecular testing of non-sputum samples, extended treatment and surgery where needed, with how many people receive treatment and how many stay on it.
Health Outcomes and Complications
Long-term effects covered include Post-TB lung disease, drug resistance, catastrophic household costs and TB deaths, along with other conditions that often occur alongside extrapulmonary tuberculosis.
Healthcare Infrastructure and Accessibility
The report looks at TB clinics and treatment centres, diagnostic laboratories and molecular testing, community health workers and medicine supply chains, the health workforce, and the physical, financial and distance barriers to care, including how people use public and private services.
Economic and Socioeconomic Burden
Extrapulmonary Tuberculosis worldwide: health cover, spending and research
WHO reports that 4.5 billion people were not fully covered by essential health services in 2021.[1] The world scores 71 out of 100 on the WHO universal health coverage index (2023).[2] People pay 17.3% of all health spending out of their own pockets (2023).[3] ClinicalTrials.gov lists 18 studies on Extrapulmonary Tuberculosis that are recruiting, active or about to start worldwide.[4]
It describes the costs of extrapulmonary tuberculosis to health systems and households, including out-of-pocket spending and lost productivity, and how government, donors and NGOs fund the response.
Government Initiatives and Public Health Interventions
Worldwide guidance and funding for extrapulmonary tuberculosis include WHO End TB Strategy, Stop TB Partnership, The Global Fund to Fight AIDS, Tuberculosis and Malaria and UN High-Level Meeting on TB Commitments. The report reviews national programmes, donor and NGO funding, and what is known about their impact.
Historical Trends and Comparative Analysis
Year-wise trends and changes across survey rounds are shown and compared with peer countries, with the data collection year and reporting period stated for each figure.
Healthcare Gaps and Unmet Needs
The report names gaps in screening, diagnosis, treatment and access, the high-risk and underserved communities most affected, and where reliable data is missing.
Future Burden and Public Health Outlook
It looks ahead at the likely future burden of extrapulmonary tuberculosis, the healthcare it will need and the areas most vulnerable.
Key Findings and Strategic Recommendations
The report closes with key findings, the population groups to prioritise and recommendations on where to target resources. Figures come from WHO Global Tuberculosis Report, National TB Prevalence Surveys, National TB Programme Notification Data and Global Burden of Disease (IHME). Reported cases, survey estimates and modelled estimates are kept apart, and missing figures are named as data gaps.
The extrapulmonary tuberculosis burden in this report is segmented by type, age group, gender, population group, area, socioeconomic status and care setting. Here's a breakdown of the segmentation
By Type
- TB Lymphadenitis
- TB Meningitis
- Spinal and Bone TB
- Abdominal TB
By Age Group
- Children 0–14 Years
- Adolescents and Young Adults 15–24 Years
- Adults 25–54 Years
- Adults 55 Years and Over
By Population Group
- People Living With HIV
- People With Diabetes
- Undernourished People
- Household Contacts
- Miners and Prisoners
- Migrants and the Urban Poor
By Area
- Urban
- Rural
- Informal Settlements and Camps
By Socioeconomic Status
- Poorest Households
- Lower-Middle
- Middle
- Upper-Middle
- Richest Households
By Care Setting
- Public Health Facilities
- Private Facilities and Pharmacies
- NGO and Faith-Based Facilities
- Community-Based Care